Literature DB >> 9420836

Cost-effectiveness analysis for management of patients with ischemic heart disease.

A S Iskandrian.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 9420836     DOI： 10.1016/s1071-3581(05)80046-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  9 in total

1.  Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction.

Authors:  L Goldman; S T Sia; E F Cook; J D Rutherford; M C Weinstein
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

2.  Cost effectiveness of tissue plasminogen activator.

Authors:  T H Lee
Journal:  N Engl J Med       Date:  1995-05-25       Impact factor: 91.245

3.  Economic analysis of health care technology. A report on principles. Task Force on Principles for Economic Analysis of Health Care Technology.

Authors: 
Journal:  Ann Intern Med       Date:  1995-07-01       Impact factor: 25.391

Review 4.  Alternative perspectives on the biased foundations of medical technology assessment.

Authors:  G A Diamond; T A Denton
Journal:  Ann Intern Med       Date:  1993-03-15       Impact factor: 25.391

5.  Bayesian comparison of cost-effectiveness of different clinical approaches to diagnose coronary artery disease.

Authors:  R E Patterson; C Eng; S F Horowitz; R Gorlin; S R Goldstein
Journal:  J Am Coll Cardiol       Date:  1984-08       Impact factor: 24.094

6.  Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease.

Authors:  R E Patterson; R L Eisner; S F Horowitz
Journal:  Circulation       Date:  1995-01-01       Impact factor: 29.690

Review 7.  Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis.

Authors:  R Gianrossi; R Detrano; D Mulvihill; K Lehmann; P Dubach; A Colombo; D McArthur; V Froelicher
Journal:  Circulation       Date:  1989-07       Impact factor: 29.690

8.  Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.

Authors:  D B Mark; M A Hlatky; R M Califf; C D Naylor; K L Lee; P W Armstrong; G Barbash; H White; M L Simoons; C L Nelson
Journal:  N Engl J Med       Date:  1995-05-25       Impact factor: 91.245

9.  Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.

Authors:  L Goldman; M C Weinstein; P A Goldman; L W Williams
Journal:  JAMA       Date:  1991-03-06       Impact factor: 56.272
  9 in total
  1 in total

Review 1.  Cost-effectiveness analysis in diagnosis of cardiac disease: overview of its rationale and method.

Authors:  R E Patterson
Journal:  J Nucl Cardiol       Date:  1996 Jul-Aug       Impact factor: 5.952
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.